Elizabeth Hohmann, MD

Massachusetts General Hospital

Disclosure(s): Gilead: Advisor/Consultant; Kowa Pharmaceuticals: Advisor/Consultant; Tend, Inc: Grant/Research Support

Poster(s):

• 1155 - Short vs. Long Symptom Duration Prior to Remdesivir for Hospitalized Patients with COVID-19
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET